IJEDO | Italian Journal of Eating Disorders and Obesity

Articolo originale
Glucagon-like Peptide 1 Receptor Agonists and Obesity Associated with Eating Disorders
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are effective medications for managing obesity and related metabolic complications. However, their use presents specific challenges when obesity is coexisting with eating disorders.
Dalle Grave Riccardo
IJEDO 2024;6:15-24 | doi:10.32044/ijedo.2024.02
Published: 18 Novembre 2024
FullText | Pdf
Articolo originale
Forty years of the Villa Garda Eating Disorder Clinical Service: From the Eclectic Disease Model to the Psychological Multistep CBT-E Model
The Department of Eating and Weight Disorders at Villa Garda Hospital holds the distinction of being the inaugural unit in Italy solely devoted to the intensive treatment of eating disorders. Established in 1984, the unit has been notable for its pioneering approach, seamlessly integrating clinical practice with research endeavours. This unique blend has significantly shaped the management protocols for eating disorders both within Italy and on a global scale.
Dalle Grave Riccardo, Calugi Simona
IJEDO 2024;6:1-14 | doi:10.32044/ijedo.2024.01
Published: 18 Luglio 2024
FullText | Pdf
Original article
Obesity and eating disorders: an interactive and complex coexistence
Obesity is the medical condition most frequently observed in people with eating disorders. It often coexists with binge-eating disorder and with some cases of bulimia nervosa, night eating syndrome, and atypical anorexia nervosa. Obesity can precede the onset of eating disorders, sometimes representing a risk factor for their onset, or can be in part the consequence of recurrent binge-eating episodes.
Dalle Grave Riccardo
IJEDO 2023;5:12-20 | doi:10.32044/ijedo.2023.04
Published: 7 Dicembre 2023
FullText | Pdf
Brief Report
Putative mediators of enhanced cognitive behaviour therapy for adolescents with anorexia nervosa
The effectiveness of enhanced cognitive behaviour therapy (CBT-E) for adolescents with anorexia has been supported by several cohort studies and a non-randomized effectiveness trial comparing this treatment with family-based treatment (FBT). However, although many patients achieve a good outcome, a significant proportion still has residual psychopathology at the end of the CBT-E.
Dalle Grave Riccardo, Calugi Simona
IJEDO 2023;5:8-11 | doi:10.32044/ijedo.2023.03
Published: 13 Marzo 2023
FullText | Pdf
Commentary
American Academy of Pediatrics Clinical Practice Guideline for the Evaluation and Treatment of Children and Adolescents with Obesity: What we can learn versus what we can apply in clinical practice
The American Academy of Pediatrics released its first guideline for the evaluation and treatment of children and adolescents with obesity, which was negatively received by eating disorders experts and anti-weight stigma activists around the world. As a primary care physician and an eating disorders practitioner, dealing with the devastating effects of both excess weight and eating disorders in kids and teens, I read with great interest the recently published guideline.
Wehbe Chidiac Carole
IJEDO 2023;5:4-7 | doi:10.32044/ijedo.2023.02
Published: 1 Marzo 2023
FullText | Pdf

Glucagon-like Peptide 1 Receptor Agonists and Obesity Associated with Eating Disorders

Forty years of the Villa Garda Eating Disorder Clinical Service: From the Eclectic Disease Model to the Psychological Multistep CBT-E Model

Obesity and eating disorders: an interactive and complex coexistence

Putative mediators of enhanced cognitive behaviour therapy for adolescents with anorexia nervosa

American Academy of Pediatrics Clinical Practice Guideline for the Evaluation and Treatment of Children and Adolescents with Obesity: What we can learn versus what we can apply in clinical practice